Pending AI

AI is becoming more essential as scientific data is becoming more abundant and more accessible. In order to offer high-quality evidence-based solutions our AI models are trained across massive federated datasets that contain millions of data points. AI-based solutions can then be employed to augment the cognitive abilities of individual scientists and teams to enable them to make more informed decisions in drug design.

Pending.AI is developing AI solutions to empower scientists in the pharmaceutical industry to design, make, and test new drugs to treat diseases.

We are now working on:

- De novo Drug Design
- Synthesis Planning
- High-throughput Chemistry
- Structure-based Drug Design

The AI models are trained across massive federated datasets that contain millions of data points in order to offer high-quality solutions. AI is becoming more essential as scientific data is becoming more abundant and more accessible. AI-based solutions are used by scientists and teams to assist them in making more informed decisions.